{{chembox
| Verifiedfields = changed
| verifiedrevid = 477317096
| ImageFile=alfacalcidol.png
| ImageFile2=Alfacalcidol ball-and-stick.png
| IUPACName=(1''R'',3''S'',5''Z'')-5-[(2''E'')-2-[(1''R'',3a''S'',7a''R'')-7a-Methyl-1-[(2''R'')-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1''H''-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
| OtherNames=Alphacalcidol; 1-Hydroxycholecalciferol
|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = URQ2517572
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 31186
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 32540
| InChI = 1/C27H44O2/c1-18(2)8-6-9-19(3)24-13-14-25-21(10-7-15-27(24,25)5)11-12-22-16-23(28)17-26(29)20(22)4/h11-12,18-19,23-26,28-29H,4,6-10,13-17H2,1-3,5H3/b21-11+,22-12-/t19-,23-,24-,25+,26+,27-/m1/s1
| InChIKey = OFHCOWSQAMBJIW-AVJTYSNKBM
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C27H44O2/c1-18(2)8-6-9-19(3)24-13-14-25-21(10-7-15-27(24,25)5)11-12-22-16-23(28)17-26(29)20(22)4/h11-12,18-19,23-26,28-29H,4,6-10,13-17H2,1-3,5H3/b21-11+,22-12-/t19-,23-,24-,25+,26+,27-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OFHCOWSQAMBJIW-AVJTYSNKSA-N
| CASNo_Ref = {{cascite|correct|CAS}}
| CASNo=41294-56-8
| PubChem=5282181
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4445376
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01518
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01436
| SMILES = O[C@@H]1CC(\C(=C)[C@@H](O)C1)=C\C=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C
}}
|Section2={{Chembox Properties
| Formula=C<sub>27</sub>H<sub>44</sub>O<sub>2</sub>
| MolarMass=400.64 g/mol
| Appearance=
| Density=
| MeltingPt=
| BoilingPt=
| Solubility=
  }}
|Section6={{Chembox Pharmacology
| ATCCode_prefix = A11
| ATCCode_suffix = CC03
}}
|Section7={{Chembox Hazards
| MainHazards=
| FlashPt=
| AutoignitionPt =
  }}
}}

'''Alfacalcidol''' (or '''1-hydroxycholecalciferol''') is an analogue of [[vitamin D]] used for supplementation in humans and as a poultry feed additive.

Alfacalcidol has a weaker impact on [[calcium metabolism]]<ref>{{cite journal | last1 = | first1 = | year = 2009 | title = Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women | pmc = 2781231| journal = Clin Cases Miner Bone Metab | volume = 6 | issue = 2| pages = 169–173 | pmid=22461169}}</ref> and [[parathyroid hormone]] levels<ref>{{cite journal | last1 = | first1 = | year = 2008 | title = Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial | url = http://www.jptcp.com/cjcp07017_wazny_e36-e43v2-r101690 | journal = Can J Clin Pharmacol | volume = 15 | issue = 1| pages = e36–e43 }}</ref> than [[calcitriol]], however alfacalcidol has significant effects on the [[immune system]], including [[regulatory T cells]].<ref>Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease, Autoimmunity Reviews, August 2010;</ref> It is considered to be a more useful form of [[vitamin D]] supplementation, mostly due to much longer half-life and lower kidney load.<ref>{{cite journal | last1 = | first1 = | date = Mar 2006 | title = Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis | url = | journal = Rheumatol Int. | volume = 26 | issue = 5| pages = 445–53 | doi = 10.1007/s00296-005-0073-4 | pmid = 16283320 }}</ref> It is the most commonly prescribed vitamin D metabolite for patients with [[end stage renal disease]], given that impaired renal function alters the ability to carry out the second [[hydroxylation]] step required for the formation of the physiologically active form of vitamin D, [[1,25-dihydroxyvitamin D3]]. Alfacalcidol is an active vitamin D3 metabolite, and therefore does not require the second [[hydroxylation]] step in the [[kidney]].<ref>{{cite journal | pmid = 11770836 | volume=39 | title=Alfacalcidol in the therapy of renal bone disease. | date=Dec 2001 | journal=Int J Clin Pharmacol Ther | pages=546–50 | doi=10.5414/cpp39546}}</ref>

Used as a poultry feed additive, it prevents [[tibial dyschondroplasia]] and increases [[phytate]] bioavailability.<ref>[http://www.vitaminderivatives.com VDI Product Data]</ref>{{or|date=October 2010}}

==Trade names==
Pharmaceutical trade names include AlphaD and One-Alpha.

==References==
{{Reflist|30em}}


{{Vitamins}}
{{Vitamin D receptor modulators}}

[[Category:Secosteroids]]